Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomesJulian Musa, Thomas G. P. Grünewald, Gal Mazor et al.|Nature Communications|2019Cited by 72
Reticulocalbin 2 as a Potential Biomarker and Therapeutic Target for AtherosclerosisJing Li, Weibin Shi|Cells|2022Cited by 12
VirusImmu: a novel ensemble machine learning approach for viral immunogenicity predictionJing Li, Jing Zhang, Zhongpeng Zhao et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 3